Brief: Cytrx Corp - Orphazyme Announces Global Brand Name Miplyffa For Arimoclomol Ahead Of Prospective FDA And EMA Approvals

LadRx

08/03/2021 13:28

March 8 (Reuters) - CytRx Corp  CYTR.PK :
    * CYTRX CORP - ORPHAZYME ANNOUNCES GLOBAL BRAND NAME
MIPLYFFA FOR
ARIMOCLOMOL AHEAD OF PROSPECTIVE FDA AND EMA APPROVALS
    * CYTRX CORP - ORPHAZYME HAS EXPANDED ITS NPC EARLY ACCESS
PROGRAM
IN U.S. AND OPENED SIMILAR PROGRAMS IN FRANCE AND GERMANY
    * CYTRX CORP - ORPHAZYME EXPECTS TO RECEIVE A DECISION ON
EUROPEAN
REGULATORY APPROVAL FOR ARIMOCLOMOL FOR NPC BY Q4 2021
    * CYTRX CORP - ORPHAZYME PROJECTS ARIMOCLOMOL SALES FOR NPC
THIS
YEAR OF UP TO $20 MILLION

Source text for Eikon:  ID:nBw4ZxFdva 
Further company coverage:  CYTR.PK 

 ((Reuters.Briefs@thomsonreuters.com;))